S11E1090 24:22

Published: August 21, 2020

A recent study suggests that SGLT2 drugs – now shown to dramatically improve cardiovascular and renal outcomes in a wide variety of patients – have a higher incidence of euglycemic DKA than previously thought.  If pharmacists see more of this ADR, how do we treat appropriately – especially when a patient’s sugars may not be very high?This episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/3gy7F4O See omnystudio.com/listener for privacy information.

View All Episodes